Rifabutin-associated uveitis in an immunocompetent individual with Mycobacterium simiae.
Jetton
Jacquelyn
J
Gaviria
Juan G
JG
Patterson
Thomas F
TF
Johnson
Daniel A
DA
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000382:microbiology; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification*; D011014:Pneumonia / Q000188:drug therapy* / Q000382:microbiology; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017828:Rifabutin / Q000009:adverse effects*; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D017828:Rifabutin; C009935:prednisolone acetate; D011239:Prednisolone